162 related articles for article (PubMed ID: 8555595)
1. Extracorporeal endotoxin removal in a canine model of septic shock.
Lonergan JM; Orlowski JP; Sato T; McHugh MJ; Zborowski M
ASAIO J; 1994; 40(3):M654-7. PubMed ID: 8555595
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal adsorption of endotoxin.
Staubach KH; Rosenfeldt JA; Veit O; Bruch HP
Ther Apher; 1997 Feb; 1(1):67-74. PubMed ID: 10225785
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of extracorporeal perfusion for septic shock.
Sato T; Orlowski JP; Zborowski M
ASAIO J; 1993; 39(3):M790-3. PubMed ID: 8268646
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
[TBL] [Abstract][Full Text] [Related]
6. Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine endotoxin shock.
Bende S; Bertók L
Circ Shock; 1986; 19(2):239-44. PubMed ID: 3719924
[TBL] [Abstract][Full Text] [Related]
7. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
Aoki H; Kodama M; Tani T; Hanasawa K
Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
[TBL] [Abstract][Full Text] [Related]
8. Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber.
Hanasawa K; Tani T; Oka T; Yoshioka T; Aoki H; Endo Y; Kodama M
Prog Clin Biol Res; 1988; 264():337-41. PubMed ID: 2837785
[No Abstract] [Full Text] [Related]
9. Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock.
Nakamura T; Suzuki Y; Shimada N; Ebihara I; Shoji H; Koide H
Blood Purif; 1998; 16(4):179-86. PubMed ID: 9736787
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic method against septic shock--removal of endotoxin using extracorporeal circulation.
Kodama M; Hanasawa K; Tani T
Adv Exp Med Biol; 1990; 256():653-64. PubMed ID: 2183569
[No Abstract] [Full Text] [Related]
11. The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis.
De Rosa S; Villa G; Ronco C
Artif Organs; 2020 Feb; 44(2):184-186. PubMed ID: 31386769
[TBL] [Abstract][Full Text] [Related]
12. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
[TBL] [Abstract][Full Text] [Related]
13. Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature.
Cruz DN; de Cal M; Piccinni P; Ronco C
Contrib Nephrol; 2010; 167():77-82. PubMed ID: 20519901
[TBL] [Abstract][Full Text] [Related]
14. Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock.
Tetta C; Gianotti L; Cavaillon JM; Wratten ML; Fini M; Braga M; Bisagni P; Giavaresi G; Bolzani R; Giardino R
Crit Care Med; 2000 May; 28(5):1526-33. PubMed ID: 10834707
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanical assistance in the treatment of endotoxic and septicemic shock.
Hanasawa K; Aoki H; Yoshioka T; Matsuda K; Tani T; Kodama M
ASAIO Trans; 1989; 35(3):341-3. PubMed ID: 2557067
[TBL] [Abstract][Full Text] [Related]
16. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
17. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
[TBL] [Abstract][Full Text] [Related]
18. Push-pull sorbent-based pheresis treatment in an experimental canine endotoxemia model: preliminary report.
Peter AT; Ash SR; Steczko J; Turek JJ; Blake DE; Carr DJ; Knab WR; Bosley RH
Int J Artif Organs; 1999 Mar; 22(3):177-88. PubMed ID: 10357246
[TBL] [Abstract][Full Text] [Related]
19. Effect of an endotoxin-removing column containing immobilized polymyxin B fiber in a patient with septic shock from gram-positive infection.
Iwama H; Komatsu T
Acta Anaesthesiol Scand; 1998 May; 42(5):590-3. PubMed ID: 9605378
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin).
Shoji H
Ther Apher Dial; 2003 Feb; 7(1):108-14. PubMed ID: 12921125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
